Multiple sclerosis (MS)
253 results
230 - 253
Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis- Treatment with disease‐modifying drugs for people with a first clinical attack suggestive of multiple sclerosis
- Psychological interventions for multiple sclerosis
- alemtuzumab versus interferon beta 1a for relapsing‐remitting multiple sclerosis
Raynaud's phenomenon (RP) or white finger disease - Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis (RRMS): a network meta-analysis
- Natalizumab for relapsing remitting multiple sclerosis: Cochrane systematic review
- Fingolimod for relapsing‐remitting multiple sclerosis
- Interventions for fatigue and weight loss in adults with advanced progressive illness
Medical marijuana for various neurologic conditions: mixed outcomes- Muscle weakness and paralysis symptom
- Gait disturbances
- Cholinesterase inhibitors for rarer dementias associated with neurological conditions: Cochrane systematic review
- Primary Sjögren's syndrome
- Vertigo
- Corticosteroids for treating optic neuritis
- Pharmacological treatments for fatigue associated with palliative care: Cochrane systematic review
- Immunomodulators and immunosuppressants for relapsing‐remitting multiple sclerosis: a network meta‐analysis
- Pruritus
- Effectiveness and cost‐effectiveness of home palliative care services for adults with advanced illness and their caregivers
- Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction
- Trigeminal neuralgia and other facial pain
- Lyme borreliosis (LB)